A lung cancer drug developed by Akeso Inc. extended patients’ lives by about four months in a late-stage trial in China, ...

Ivonescimab reduced the risk of death by one-third compared to chemotherapy in a China-based study that’s seen as an ...

An experimental lung cancer drug from Akeso and Summit Therapeutics reduced the risk of death by 34% in a late-stage trial, according to data released Sunday.

An experimental drug developed by China-based Akeso helped patients with advanced squamous non-small cell lung cancer live 15% longer than BeOne Medicines' immunotherapy Tevimbra, and cut the risk ...

It’s the moment of truth for Akeso’s ivonescimab, and to many, a high-stakes test for China’s booming biotech industry. | ...

When Garen was diagnosed with lung cancer, biomarker testing helped focus his treatment options, inform his treatment decisions, and finding the appropriate treatment has allowed him to maintain his ...

In Lilly's Libretto-432 ASCO readout, Retevmo showed an 83% reduction in disease progression or death when used as an adjuvant therapy in patients with early-stage RET fusion-positive lung cancer.

A woman in England has died after being diagnosed with lung cancer, despite being a non-smoker. Juliet Fielder, known as ...

We get one body, one mind, one soul and what are we going to do with it?" Lipchock, who lives in Washington Township with her ...

Singer Barry Manilow addresses recent health issues in a sneak-peek of his upcoming Good Morning America interview. Manilow revealed in December that he had been diagnosed with lung cancer. The ...

Matthew Herper covers medical innovation — both its promise and its perils. CHICAGO — Ivonescimab, a drug that combines the activity of two of the best-selling cancer medicines, reduced the risk of ...

Lung cancer causes abnormal cells to grow in your lungs. You are at higher risk for lung cancer if you are a current smoker or have smoked regularly in the past. But anyone can get lung cancer. In ...